APONTIS PHARMA
APONTIS PHARMA is a pharma company, headquartered in Germany.
Entry
2018
Hold
6yr
Exit
2024
Est. EV
–
Who owns APONTIS PHARMA?
APONTIS PHARMA was owned by Paragon Partners through Paragon Fund II (2014 vintage) from 2018 to 2024, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-02
Key facts
HQGermany
SectorPharma
StatusActive
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024
More from Paragon Fund II
Other portfolio companies in the same fund.
Asic Robotics
Exited 2026
Industrials
Switzerland· 2018
Switzerland· 2018to
inprotec
Exited 2022
Industrials
Germany· 2018
Germany· 2018to
UNICEPTA
Exited 2024
Business ServicesGermany· 2018
Germany· 2018to
chicco di caffe
Exited 2023
Business ServicesGermany· 2017
Germany· 2017to
Condecta
Exited 2024
Business ServicesSwitzerland· 2017
Switzerland· 2017to
WEMAS
Exited 2023
IndustrialsGermany· 2017
Germany· 2017to
More PE-backed in Pharma
Comparable pharma deals from other GPs.
France
Spain
UKData refreshed weekly · Sourced from public filings